|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the WBMD 10-K filed Apr 30, 2007. Executive
Officers
Mark J. Adler, M.D., has been a member of our Board
of Directors since September 2005 and a member of Emdeon’s
Board of Directors since September 2000. Dr. Adler is an
oncologist and has, for more than five years, been CEO and
Medical Director of the San Diego Cancer Center and a
director of the San Diego Cancer Research Institute. Until
April 2006, he had also been, for more than five years, the
Chief Executive Officer of the internal medicine and oncology
group of Medical Group of North County, which is based in
San Diego, California, and he continues to be a member of
that Medical Group. He also serves on the Scientific Advisory
Board of Red Abbey Venture Partners, a private investment firm.
Table of Contents
Neil F. Dimick has been a member of our Board of
Directors since September 2005 and a member of Emdeon’s
Board of Directors since December 2002. Mr. Dimick served
as Executive Vice President and Chief Financial Officer of
AmerisourceBergen Corporation, a wholesale distributor of
pharmaceuticals, from 2001 to 2002 and as Senior Executive Vice
President and Chief Financial Officer and as a director of
Bergen Brunswig Corporation, a wholesale distributor of
pharmaceuticals, for more than five years prior to its merger in
2001 with AmeriSource Health Corporation to
form AmerisourceBergen. He also serves as a member of the
Boards of Directors of the following companies: Alliance Imaging
Inc., a provider of outsourced diagnostic imaging services to
hospitals and other healthcare companies; Global Resources
Professionals, an international professional services firm that
provides outsourced services to companies on a project basis;
Mylan Laboratories, Inc., a pharmaceutical manufacturer; and
Thoratec Corporation, a developer of products to treat
cardiovascular disease.
Nan-Kirsten Forte has, since July 2005, served as
Executive Vice President, Consumer Services of our company. For
more than five years prior to that, Ms. Forte served as an
Executive Vice President of WebMD, Inc., a subsidiary that
Emdeon contributed to our company in connection with our initial
public offering, where she focused on the consumer portals. From
1997 until its merger with Emdeon in November 1999,
Ms. Forte was President, Programming and Product
Development of Medcast, Greenberg News Networks. Prior to
Medcast, she was President of Health of iVillage where she
launched iVillage’s first health channel, called
“Better Health.” Ms. Forte has been a member of
the American Medical Writers Association and the American
Medical Illustrators Association.
Craig Froude has served, since July 2005, as Executive
Vice President — WebMD Health Services of our company.
From October 2002 until July 2005, Mr. Froude served as
Senior Vice President and General Manager of our Healthcare
Services Group, which conducts our private portals business and
which Emdeon contributed to our company in connection with our
initial public offering. From December 1996 until its
acquisition by Emdeon in October 2002, Mr. Froude served as
Chairman and Chief Executive Officer of WellMed, Inc., a
predecessor to our Healthcare Services Group.
Wayne T. Gattinella has served, since May 2005, as Chief
Executive Officer and President of our company and as a member
of our Board of Directors. He has been Chief Executive Officer
of Emdeon’s WebMD segment since April 2005 and President of
that segment since August 2001. Before joining Emdeon,
Mr. Gattinella was Executive Vice President and Chief
Marketing Officer for PeoplePC, an Internet service provider,
from April 2000 to August 2001. From February 1998 to March
2000, Mr. Gattinella was President of North America for
MemberWorks, Inc., a marketing services company.
Jerome C. Keller has been a member of our Board of
Directors since September 2005. From 1997 until he retired in
October 2005, Mr. Keller served as Senior Vice President,
Sales and Marketing at Martek Biosciences Corporation, a company
that develops and sells microalgae products, and he has served,
since October 2005, as a member of its Board of Directors. He
served as Vice President of Sales for Merck & Co. Inc.,
a pharmaceutical company, from 1986 to 1993.
James V. Manning has been a member of our Board of
Directors since September 2005. He has been a member of
Emdeon’s Board of Directors since September 2000 and, prior
to that, was a member of a predecessor company’s Board of
Directors for more than five years.
Abdool Rahim Moossa, M.D. has been a member of our
Board of Directors since September 2005. He currently serves as
the Professor of Surgery and Emeritus Chairman, Associate Dean
and Special Counsel to the Vice Chancellor for Health Sciences,
Director of Tertiary and Quaternary Referral Services for the
University of California, San Diego, or UCSD. Prior to that
he served as Professor and Chairman, Department of Surgery, UCSD
from 1983 to 2003. He also serves as a member of the Board of
Directors of U.S. Medical Instruments, Inc., a
technology-based medical device manufacturer, and the Foundation
for Surgical Education.
Stanley S. Trotman, Jr. has been a member of our
Board of Directors since September 2005. Mr. Trotman
retired in 2001 from UBS Financial Services, Inc. after it
acquired, in 2000, PaineWebber Incorporated, an investment
banking firm where he had been a Managing Director with the
Health Care Group since 1995. He serves as a member of the Board
of Directors of American Shared Hospital Services, a public
company that
Table of Contents
provides radiosurgery services to medical centers for use in
brain surgery. He also serves as a director of Ascend Health
Care Corp., a privately-held company that provides services to
acute psychiatric patients.
Anthony Vuolo has, since May 2005, served as Executive
Vice President and Chief Financial Officer of our company.
Mr. Vuolo served as Executive Vice President, Business
Development of Emdeon from May 2003 until July 2005. From
September 2000 to May 2003, Mr. Vuolo was Executive Vice
President and Chief Financial Officer of Emdeon. Prior to that,
Mr. Vuolo served in senior management positions at Emdeon
and its predecessors for more than five years.
Douglas W. Wamsley has, since July 2005, served as
Executive Vice President, General Counsel and Secretary of our
company. From September 2001 until July 2005, Mr. Wamsley
served as Senior Vice President — Legal of Emdeon,
focusing on its WebMD segment. Prior to joining Emdeon,
Mr. Wamsley served as Executive Vice President and General
Counsel of Medical Logistics, Inc. from February 2000 through
July 2001.
Martin J. Wygod has, since May 2005, served as Chairman
of the Board of our company. In addition, he has served as
Emdeon’s Chairman of the Board since March 2001 and as a
member of the Board of Directors of Emdeon since September 2000.
From October 2000 until May 2003, he also served as
Emdeon’s Chief Executive Officer and, from September 2000
until October 2000, also served as Co-CEO of Emdeon. He is also
engaged in the business of racing, boarding and breeding
thoroughbred horses, and is President of River Edge Farm, Inc.
Steven Zatz, M.D. has, since July 2005, served as
Executive Vice President, Professional Services of our company.
From October 2000 to July 2005, Dr. Zatz has served as an
Executive Vice President of WebMD, Inc., a subsidiary that
Emdeon contributed to our company in connection with our initial
public offering, where he focused on the physician portals, and
also served as an Executive Vice President of Emdeon.
Dr. Zatz was Senior Vice President, Medical Director of
CareInsite, Inc. from June 1999 until its acquisition by Emdeon
in September 2000. Prior to joining CareInsite, Dr. Zatz
was senior vice president of RR Donnelly Financial in charge of
its healthcare business from October 1998 to May 1999. From
August 1995 to May 1998, Dr. Zatz was President of
Physicians’ Online, an online portal for physicians.
No family relationship exists among any of our directors or
executive officers. No arrangement or understanding exists
between any director or executive officer of WebMD and any other
person pursuant to which any of them were selected as a director
or executive officer; provided, however, that Emdeon has the
ability to cause the election or removal of our entire Board of
Directors. See “Corporate Governance — Control by
Emdeon” below.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
